Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **myenteric plexus (Auerbach plexus)** is a network of neurons forming a major part of the enteric nervous system, located between the circular and longitudinal muscle layers of the intestinal wall[1][3][4][7]. It coordinates intestinal muscle activity, mediating peristalsis and overall gut motility, and integrates signals from the central and autonomic nervous systems[1][2][3][4][6][7]. Dysfunction of the myenteric plexus is implicated in motility disorders (such as Hirschsprung disease and achalasia) and is affected by drugs acting on enteric neurons, such as opioids (which reduce gut motility by targeting neuronal signaling within the plexus)[7]. The plexus itself is a multicellular structure, not a specific receptor, enzyme, or molecular target, so it is not considered a therapeutic target per se, but rather a functional anatomical network whose neuronal components may be targeted indirectly.
Inhibition or modulation of neurotransmitter release on myenteric neurons (e.g., opioids reduce acetylcholine release, slowing gut motility)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myenteric plexus.